Interestingly, collagen type I and CXCR4 were predominantly co-localized, and the number of double-positive cells was significantly increased in the bevacizumab-resistant tumours (Fig. 3b,c and Supplementary Fig. 3b,c). The gene discussed is CXCR4; the disease is neoplasm.